Patent ID: 11911381
Assignee: SUMITOMO PHARMA CO. LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 5:
6. The compound of claim 4, wherein the crystal form is characterized by a powder x-ray diffraction pattern having diffraction angle (2θ°) peaks of 5.3°±0.2°, 9.9°±0.2°, 10.6°±0.2°, 11.9°±0.2°, 13.1°±0.2°, 13.6°±0.2°, 15.9°±0.2°, 16.3°±0.2°, 17.9°±0.2°, 18.9°±0.2°, and 21.2°±0.2°.